Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,571 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dutch Ophthalmic, USA | $367.20 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $291.63 | 7 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $264.05 | 3 | $0 (2021) |
| Ocular Therapeutix, Inc. | $131.91 | 2 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $128.62 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $118.04 | 6 | $0 (2023) |
| Shire North American Group Inc | $114.69 | 1 | $0 (2018) |
| Genentech USA, Inc. | $56.77 | 3 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $43.92 | 2 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $24.97 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.49 | 4 | Johnson & Johnson Surgical Vision, Inc. ($43.92) |
| 2023 | $171.50 | 3 | Dutch Ophthalmic, USA ($116.54) |
| 2022 | $199.70 | 4 | Dutch Ophthalmic, USA ($149.95) |
| 2021 | $188.65 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($176.79) |
| 2020 | $157.18 | 3 | Ocular Therapeutix, Inc. ($117.18) |
| 2019 | $278.46 | 6 | Sun Pharmaceutical Industries Inc. ($128.62) |
| 2018 | $252.69 | 4 | Novartis Pharmaceuticals Corporation ($138.00) |
| 2017 | $238.14 | 5 | Novartis Pharmaceuticals Corporation ($137.43) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Johnson & Johnson Surgical Vision, Inc. | VERITAS Vision System (Device) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Optics | ||||||
| 09/24/2024 | Johnson & Johnson Surgical Vision, Inc. | VERITAS Vision System (Device) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Optics | ||||||
| 05/23/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Ophthalmology | ||||||
| 02/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/04/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/13/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $24.97 | General |
| Category: Ophthalmology | ||||||
| 02/27/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $116.54 | General |
| Category: Ophthalmology | ||||||
| 11/16/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/11/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/30/2022 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 08/29/2022 | Dutch Ophthalmic, USA | EVA, combined machine (Device) | Food and Beverage | In-kind items and services | $149.95 | General |
| Category: Ophthalmology | ||||||
| 06/01/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/25/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS (Device), enVista MX60 IOL, AMVISC PLUS | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Ophthalmology | ||||||
| 04/29/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $114.29 | General |
| Category: Ophthalmology | ||||||
| 10/21/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $117.18 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 06/16/2020 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/06/2020 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/30/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug), CEQUA, XELPROS | Food and Beverage | Cash or cash equivalent | $128.62 | General |
| Category: Ophthalmology | ||||||
| 10/08/2019 | Beaver-Visitec International, Inc. | — | Food and Beverage | In-kind items and services | $10.19 | General |
| 10/01/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/11/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | ENVISTA TORIC (Device) | Food and Beverage | In-kind items and services | $87.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/22/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/09/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.20 | General |
| 12/05/2018 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $107.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2018 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,545 | 8,976 | $5.2M | $1.2M |
| 2022 | 20 | 3,627 | 7,298 | $5.8M | $1.3M |
| 2021 | 21 | 3,750 | 7,066 | $5.3M | $1.2M |
| 2020 | 21 | 3,466 | 6,494 | $4.9M | $1.1M |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 169 | 1,000 | $3.0M | $681,532 | 22.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 870 | 1,873 | $375,519 | $160,429 | 42.7% |
| 92134 | Imaging of retina | Office | 2023 | 1,155 | 2,344 | $210,645 | $64,266 | 30.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 11 | 1,860 | $142,500 | $53,541 | 37.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 213 | 594 | $682,583 | $50,572 | 7.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 249 | 250 | $58,750 | $24,637 | 41.9% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 37 | 38 | $121,220 | $23,925 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 100 | 100 | $32,000 | $16,000 | 50.0% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 32 | 40 | $67,600 | $15,019 | 22.2% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 14 | 15 | $82,500 | $14,153 | 17.2% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 28 | 50 | $131,500 | $12,456 | 9.5% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 14 | 14 | $75,250 | $12,077 | 16.0% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 13 | 13 | $69,875 | $11,217 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $24,990 | $10,823 | 43.3% |
| 92250 | Photography of the retina | Office | 2023 | 264 | 321 | $41,730 | $8,232 | 19.7% |
| 66850 | Aspiration of lens material by fragmenting and aspiration | Facility | 2023 | 16 | 16 | $40,200 | $4,982 | 12.4% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2023 | 26 | 27 | $13,500 | $4,732 | 35.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 38 | 75 | $7,500 | $4,219 | 56.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 39 | 39 | $19,656 | $3,792 | 19.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 87 | 134 | $13,400 | $2,716 | 20.3% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 16 | 16 | $24,064 | $2,613 | 10.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 31 | 33 | $3,965 | $1,956 | 49.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $3,150 | $1,923 | 61.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 11 | 12 | $3,360 | $432.96 | 12.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 186 | 1,169 | $3.5M | $827,695 | 23.6% |
About Dr. Robert Blem, M.D
Dr. Robert Blem, M.D is a Ophthalmology healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528026838.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Blem, M.D has received a total of $1,571 in payments from pharmaceutical and medical device companies, with $84.49 received in 2024. These payments were reported across 32 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,571).
As a Medicare-enrolled provider, Blem has provided services to 14,388 Medicare beneficiaries, totaling 29,834 services with total Medicare billing of $4.8M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Lafayette, LA
- Active Since 05/03/2006
- Last Updated 09/22/2016
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528026838
Products in Payments
- DUREZOL (Drug) $275.43
- EVA, combined machine (Device) $266.49
- DEXTENZA (Drug) $131.91
- BROMSITE (Drug) $128.62
- XIIDRA (Drug) $114.69
- enVista MX60 IOL (Device) $114.29
- EVA Ophthalmic Surgical System (Device) $100.71
- EYLEA (Biological) $88.05
- ENVISTA TORIC (Device) $87.26
- STELLARIS (Device) $62.50
- VERITAS Vision System (Device) $43.92
- VABYSMO (Drug) $35.02
- EYLEA HD (Biological) $29.99
- Syfovre (Drug) $24.97
- Vabysmo (Drug) $21.75
- Izervay (Drug) $18.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lafayette
Shamik Bafna, Md, MD
Ophthalmology — Payments: $644,593
Ashleigh Levison, Md, MD
Ophthalmology — Payments: $77,027
Robert Courtney, Md, MD
Ophthalmology — Payments: $10,231
Dr. Paul Azar, Md, MD
Ophthalmology — Payments: $10,081
Frederick Hall, Md, MD
Ophthalmology — Payments: $9,994
Dr. Julie Foreman, M.d, M.D
Ophthalmology — Payments: $9,286